INS and Hyperglycemia: Type 2 diabetes mellitus (T2DM) is a renowned overgrowing endocrine metabolic disease, and occurs as a result of insulin resistance (IR) and inadequate insulin production, resulting in hyperglycemia, presenting a substantial burden on global healthcare systems (1, 2).